May 2016

Campaign for ALS treatments seeks commitment from Congress

But today is one of the most exciting times in ALS (amyotrophic lateral sclerosis) research history as significant progress has been made that provides tremendous hope that a treatment and cure will be found. Since 1998, ALS advocates have helped ...

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Condition:   Sickle Cell Disease
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: r-ATG;   Procedure: Bone Marrow Transplant;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Standard of Care
Sponsors:   Medical College of Wisconsin;   National Heart, Lung, and Blood Institute (NHLBI);   Blood and Marrow Transplant Clinical Trials Network;   Dana-Farber Cancer Institute;   National Marrow Donor Program
Recruiting - verified February 2017

Need for ALS research front and center at chamber breakfast

That was the main message small business owner Kevin Gosnell, who is battling amyotrophic lateral sclerosis, wanted to convey in a ... implored business leaders about the need to support research into treatments for the disease and, hopefully soon ...

Research, alternatives push ALS closer to a cure

Solazzo is one of an estimated 800,000 Americans currently diagnosed with amyotrophic lateral sclerosis, or ALS ... where he talks to ALS patients and helps them research and verify the soundness of alternative treatments. He feels a cure is on the ...

Pages